Stocks & Investing
Fri, August 2, 2024
[ Fri, Aug 02nd 2024
] - WOPRAI
Tue, June 25, 2024
[ Tue, Jun 25th 2024
] - WOPRAI
Thu, April 25, 2024
[ Thu, Apr 25th 2024
] - WOPRAI
Fri, February 16, 2024
[ Fri, Feb 16th 2024
] - WOPRAI
Tue, October 10, 2023
[ Tue, Oct 10th 2023
] - WOPRAI
Fri, August 4, 2023
[ Fri, Aug 04th 2023
] - WOPRAI
Fri, February 24, 2023
[ Fri, Feb 24th 2023
] - WOPRAI
Tue, February 1, 2022
[ Tue, Feb 01st 2022
] - WOPRAI
Fri, October 29, 2021
[ Fri, Oct 29th 2021
] - WOPRAI
Wed, August 4, 2021
[ Wed, Aug 04th 2021
] - WOPRAI
Fri, July 30, 2021
[ Fri, Jul 30th 2021
] - WOPRAI
Fri, July 16, 2021
[ Fri, Jul 16th 2021
] - WOPRAI
Fri, April 30, 2021
[ Fri, Apr 30th 2021
] - WOPRAI
[ Fri, Apr 30th 2021
] - WOPRAI
Thu, February 18, 2021
[ Thu, Feb 18th 2021
] - WOPRAI
Fri, February 12, 2021
[ Fri, Feb 12th 2021
] - WOPRAI
Wed, November 25, 2020
[ Wed, Nov 25th 2020
] - WOPRAI
Fri, November 13, 2020
[ Fri, Nov 13th 2020
] - WOPRAI
Fri, November 6, 2020
[ Fri, Nov 06th 2020
] - WOPRAI
Fri, October 30, 2020
Tue, October 13, 2020
[ Tue, Oct 13th 2020
] - WOPRAI
Mon, August 31, 2020
[ Mon, Aug 31st 2020
] - WOPRAI
Fri, August 7, 2020
[ Fri, Aug 07th 2020
] - WOPRAI
Wed, July 15, 2020
[ Wed, Jul 15th 2020
] - WOPRAI
[ Wed, Jul 15th 2020
] - WOPRAI
Thu, May 21, 2020
[ Thu, May 21st 2020
] - WOPRAI
Thu, May 7, 2020
[ Thu, May 07th 2020
] - WOPRAI
Thu, April 2, 2020
[ Thu, Apr 02nd 2020
] - WOPRAI
Wed, February 26, 2020
[ Wed, Feb 26th 2020
] - WOPRAI
Fri, February 7, 2020
[ Fri, Feb 07th 2020
] - WOPRAI
David Lebovitz Maintained (ALNY) at Strong Buy with Increased Target to $342 on, Aug 2nd, 2024
David Lebovitz of Citigroup, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Strong Buy with Increased Target from $291 to $342 on, Aug 2nd, 2024.
David has made no other calls on ALNY in the last 4 months.
There are 10 other peers that have a rating on ALNY. Out of the 10 peers that are also analyzing ALNY, 3 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Olivia Brayer of "Cantor Fitzgerald" Maintained at Hold with Increased Target to $220 on, Monday, July 22nd, 2024
- Michael Ulz of "Morgan Stanley" Maintained at Hold with Increased Target to $255 on, Friday, July 12th, 2024
- Jessica Fye of "JP Morgan" Maintained at Hold with Increased Target to $248 on, Wednesday, July 3rd, 2024
These are the ratings of the 7 analyists that currently disagree with David
- Eliana Merle of "UBS" Maintained at Strong Buy with Increased Target to $288 on, Friday, June 28th, 2024
- Paul Matteis of "Stifel" Maintained at Strong Buy with Increased Target to $295 on, Thursday, June 27th, 2024
- Ritu Baral of "TD Cowen" Maintained at Strong Buy with Increased Target to $282 on, Tuesday, June 25th, 2024
- Liisa Bayko of "Evercore ISI Group" Maintained at Buy with Increased Target to $260 on, Tuesday, June 25th, 2024
- Patrick Trucchio of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $400 on, Monday, June 24th, 2024
- Kostas Biliouris of "BMO Capital" Maintained at Buy and Held Target at $234 on, Monday, June 24th, 2024
- Keay Nakae of "Chardan Capital" Maintained at Strong Buy and Held Target at $225 on, Friday, May 3rd, 2024
